At Dextrose Technologies Pvt. Ltd., we provide antimicrobial susceptibility and efficacy testing to help researchers and product teams evaluate how bacteria and fungi respond to antimicrobial agents. Our testing supports R&D, comparative screening, formulation development, and quality investigations with controlled study conditions, clear documentation, and decision-ready reporting. Antimicrobial Susceptibility Testing (AST) Disc Diffusion Method: Zone-of-inhibition based screening for comparative susceptibility assessment. MIC Determination: Minimum Inhibitory Concentration to identify the lowest concentration that inhibits visible growth. MBC Determination: Minimum Bactericidal Concentration to assess killing endpoints where required. Time-Kill Assays (Kill Curve Studies) We evaluate antimicrobial effect over time by measuring viability at defined timepoints, enabling comparison of efficacy kinetics across agents or concentrations. Antifungal Susceptibility Testing Susceptibility assessment for fungal isolates against antifungal agents, supporting research and screening objectives. Synergistic and Combination Studies We assess combination effects (additive/synergistic/antagonistic trends) to support optimization of multi-agent strategies and formulations. Deliverables Results summary (AST/MIC/MBC/time-kill outputs as applicable) Data tables and interpretation notes aligned to your objective Clear documentation of test conditions and sample identifiers Note: Testing is intended for laboratory, research, and quality purposes. Clinical decisions should be made only by qualified healthcare professionals.